282 related articles for article (PubMed ID: 31797186)
1. Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
Labenz C; Huber Y; Michel M; Nagel M; Galle PR; Kostev K; Schattenberg JM
Dig Dis Sci; 2020 Jul; 65(7):2112-2119. PubMed ID: 31797186
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
[TBL] [Abstract][Full Text] [Related]
3. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease.
Kaps L; Labenz C; Galle PR; Weinmann-Menke J; Kostev K; Schattenberg JM
United European Gastroenterol J; 2020 Oct; 8(8):942-948. PubMed ID: 32698692
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation and the risk of myocardial infarction.
Soliman EZ; Safford MM; Muntner P; Khodneva Y; Dawood FZ; Zakai NA; Thacker EL; Judd S; Howard VJ; Howard G; Herrington DM; Cushman M
JAMA Intern Med; 2014 Jan; 174(1):107-14. PubMed ID: 24190540
[TBL] [Abstract][Full Text] [Related]
7. Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
Seki H; Kaneko H; Morita H; Itoh H; Morita K; Matsuoka S; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Yano Y; Nakamura S; Node K; Yasunaga H; Komuro I
Am J Cardiol; 2021 Aug; 152():150-157. PubMed ID: 34140140
[TBL] [Abstract][Full Text] [Related]
8. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
[TBL] [Abstract][Full Text] [Related]
9. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
Lee CH; Han KD; Kim DH; Kwak MS
Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
[TBL] [Abstract][Full Text] [Related]
10. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
11. Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.
Soliman EZ; Lopez F; O'Neal WT; Chen LY; Bengtson L; Zhang ZM; Loehr L; Cushman M; Alonso A
Circulation; 2015 May; 131(21):1843-50. PubMed ID: 25918127
[TBL] [Abstract][Full Text] [Related]
12. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
[TBL] [Abstract][Full Text] [Related]
13. Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study.
Imamura T; Doi Y; Ninomiya T; Hata J; Nagata M; Ikeda F; Mukai N; Hirakawa Y; Yoshida D; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2014 Apr; 233(2):343-348. PubMed ID: 24530960
[TBL] [Abstract][Full Text] [Related]
14. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
Arafa A; Kashima R; Matsumoto C; Kokubo Y
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
[TBL] [Abstract][Full Text] [Related]
15. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
16. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study.
Lee HY; Yang PS; Kim TH; Uhm JS; Pak HN; Lee MH; Joung B
Sci Rep; 2017 Oct; 7(1):12716. PubMed ID: 28983076
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).
Kim EJ; Yin X; Fontes JD; Magnani JW; Lubitz SA; McManus DD; Seshadri S; Vasan RS; Ellinor PT; Larson MG; Benjamin EJ; Rienstra M
Am Heart J; 2016 Jul; 177():138-44. PubMed ID: 27297859
[TBL] [Abstract][Full Text] [Related]
20. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]